Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Language
Publication year range
1.
Braz. j. med. biol. res ; v. 33(11): 1313-nov. 2000. tab
Article in English | Sec. Est. Saúde SP, SESSP-IALPROD, Sec. Est. Saúde SP, SESSP-IALACERVO | ID: biblio-1061618

ABSTRACT

Fetal hemoglobin was measured in HIV 1/2 patients under treatment with combined therapy (zidovudine and a protease inhbitor). A total of 143 patientes and 103 normal individual were investigated by the quantitative method of Betke and the semi-quantitative acid elution method of Keihauer. In the normal person, hemoglobin F makes up less than.


Subject(s)
HIV-1 , HIV , HIV-2 , Fetal Hemoglobin , Hemoglobins , Zidovudine
2.
Braz. j. med. biol. res ; 33(11): 1313-5, Nov. 2000. tab
Article in English | LILACS | ID: lil-273208

ABSTRACT

Fetal hemoglobin was measured in HIV1/2 patients under treatment with combined therapy (zidovudine and a protease inhibitor). A total of 143 patients and 103 normal individuals were investigated by the quantitative method of Betke and the semi-quantitative acid elution method of Kleihauer. In the normal person, hemoglobin F makes up less than 1 percent and an increase higher than 1.5 percent was observed in 21.4 percent of HIV patients by the method of Betke and in 24.8 percent of HIV-infected patients by the method of Kleihauer. The quantitative biochemical method of Betke showed that the populations were significantly different (two-tailed Mann-Whitney test). The reason for this hemoglobin F increase might be ascribed to the effect of zidovudine or to direct viral action on gamma chain expression. The finding of a higher F cell frequency indicated by the method of Kleihauer rather suggests that there is an increased F cell clone proliferation rather than an increase in hemoglobin F level in every cell


Subject(s)
Humans , Fetal Hemoglobin/analysis , HIV Infections/blood , Anti-HIV Agents/therapeutic use , Case-Control Studies , Chi-Square Distribution , Erythroid Precursor Cells/drug effects , HIV Infections/drug therapy , HIV Protease Inhibitors/therapeutic use , Statistics, Nonparametric , Zidovudine/therapeutic use
3.
Braz J Med Biol Res ; 33(11): 1313-5, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11050661

ABSTRACT

Fetal hemoglobin was measured in HIV1/2 patients under treatment with combined therapy (zidovudine and a protease inhibitor). A total of 143 patients and 103 normal individuals were investigated by the quantitative method of Betke and the semi-quantitative acid elution method of Kleihauer. In the normal person, hemoglobin F makes up less than 1% and an increase higher than 1.5% was observed in 21.4% of HIV patients by the method of Betke and in 24.8% of HIV-infected patients by the method of Kleihauer. The quantitative biochemical method of Betke showed that the populations were significantly different (two-tailed Mann-Whitney test). The reason for this hemoglobin F increase might be ascribed to the effect of zidovudine or to direct viral action on gamma chain expression. The finding of a higher F cell frequency indicated by the method of Kleihauer rather suggests that there is an increased F cell clone proliferation rather than an increase in hemoglobin F level in every cell.


Subject(s)
Fetal Hemoglobin/analysis , HIV Infections/blood , Anti-HIV Agents/therapeutic use , Case-Control Studies , Chi-Square Distribution , Erythroid Precursor Cells/drug effects , Fetal Hemoglobin/metabolism , HIV Infections/drug therapy , HIV Infections/metabolism , HIV Protease Inhibitors/therapeutic use , Humans , Statistics, Nonparametric , Zidovudine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...